Syphilis
91
14
18
49
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
11 trials with published results (12%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.3%
3 terminated out of 91 trials
94.2%
+7.6% vs benchmark
21%
19 trials in Phase 3/4
22%
11 of 49 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 49 completed trials
Clinical Trials (91)
Validation of Self Testing Using the INSTI Multiplex HIV1/2 Syphilis Antibody Test
Investigational Study to Evaluate the DPP® Syphilis Screen & Confirm Antibody Point-of-care Test (POCT) to Diagnose Infectious Syphilis
A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities
Pilot HIV Self-Testing And Self-collected STI Testing Strategy for Sex Worker Empowerment Study
Spotting Syphilis: A Dual Point-of-Care Syphilis Screening Initiative in a Low-Resource Healthcare Setting
Strengthening, Guidance, Health, Empowerment
Rapid HIV, Hep C, and Syphilis Screening in a Rural Street Medicine Clinic
The Feasibility of Implementing Syphilis Point-of-care Testing Into a Prenatal Clinic for People Facing Barriers to Care
Superiority of On-demand PrEP Versus PEP on Using Doxycycline for Preventing STI in MSM
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Offering Routine and Rapid Point of Care (POC) Syphilis Testing in Pregnant Patients Presenting to the Emergency Department
Cefixime Clinical Trial
Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans
Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC)
Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland
Doxi-Rio: Study on the Use of Doxycycline to Prevent Sexually Transmitted Infections in Rio de Janeiro
Linezolid for Syphilis Pilot Study
Combination Primary Care and Prevention Services for Women Who Inject Drugs and Exchange Sex in Seattle, Washington
MAGIA H3S Point of Care Test Performance for HIV, HBV, HCV, and Syphilis Screening in Pregnant Women in DR Congo
Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)